New technique to measure circulating tumor DNA in metastatic cancer may improve surveillance and outcomes

In metastatic cancer surveillance, monitoring the actual concentrations of circulating tumor DNA (ctDNA) may be critical. Researchers showed that absolute ctDNA concentration thresholds can be defined to rule out or predict impending cancer progression.

Leave A Comment

Your email address will not be published. Required fields are marked *